Insider Selling: Petmed Express Inc (PETS) Director Sells 5,000 Shares of Stock
Petmed Express Inc (NASDAQ:PETS) Director Ronald J. Korn sold 5,000 shares of the firm’s stock in a transaction that occurred on Monday, January 29th. The stock was sold at an average price of $48.38, for a total transaction of $241,900.00. Following the transaction, the director now owns 68,833 shares in the company, valued at $3,330,140.54. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.
Petmed Express Inc (PETS) opened at $44.37 on Friday. The stock has a market cap of $914.21, a P/E ratio of 26.25, a PEG ratio of 2.75 and a beta of 1.12. Petmed Express Inc has a 1 year low of $19.21 and a 1 year high of $57.80.
Petmed Express (NASDAQ:PETS) last announced its earnings results on Monday, January 22nd. The company reported $0.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.33 by $0.11. The business had revenue of $60.10 million for the quarter, compared to analyst estimates of $56.76 million. Petmed Express had a net margin of 12.84% and a return on equity of 34.04%. The company’s revenue for the quarter was up 13.6% compared to the same quarter last year. During the same period last year, the firm posted $0.24 earnings per share. analysts forecast that Petmed Express Inc will post 1.7 EPS for the current fiscal year.
A number of large investors have recently bought and sold shares of the stock. Chicago Equity Partners LLC grew its position in Petmed Express by 139.5% in the 4th quarter. Chicago Equity Partners LLC now owns 19,590 shares of the company’s stock valued at $891,000 after buying an additional 11,410 shares during the last quarter. Weatherly Asset Management L. P. purchased a new position in Petmed Express in the 4th quarter valued at $212,000. Sterling Investment Advisors Ltd. grew its position in Petmed Express by 118.5% in the 4th quarter. Sterling Investment Advisors Ltd. now owns 2,950 shares of the company’s stock valued at $134,000 after buying an additional 1,600 shares during the last quarter. Fisher Asset Management LLC grew its position in Petmed Express by 13.2% in the 4th quarter. Fisher Asset Management LLC now owns 143,513 shares of the company’s stock valued at $6,530,000 after buying an additional 16,716 shares during the last quarter. Finally, Personal Capital Advisors Corp grew its position in Petmed Express by 11.0% in the 4th quarter. Personal Capital Advisors Corp now owns 71,417 shares of the company’s stock valued at $3,249,000 after buying an additional 7,059 shares during the last quarter. Hedge funds and other institutional investors own 97.81% of the company’s stock.
A number of equities analysts have recently issued reports on PETS shares. Zacks Investment Research upgraded shares of Petmed Express from a “sell” rating to a “hold” rating and set a $50.00 target price on the stock in a research report on Friday, October 20th. Noble Financial restated a “hold” rating on shares of Petmed Express in a research report on Friday, October 27th. BidaskClub upgraded shares of Petmed Express from a “buy” rating to a “strong-buy” rating in a research report on Saturday, December 9th. Finally, Northcoast Research set a $58.00 target price on shares of Petmed Express and gave the stock a “buy” rating in a research report on Wednesday, January 3rd. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and three have issued a buy rating to the company. Petmed Express presently has a consensus rating of “Hold” and a consensus target price of $42.80.
About Petmed Express
PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.
Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.